TMO — Thermo Fisher Scientific Inc. stock price, charts and financials

QT61Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (NYSE: TMO) is a Healthcare company in the Medical - Diagnostics & Research industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
594.43
+0.43+0.07%
TMOQT61Thermo Fisher Scientific Inc.·NYSE
594.43+0.07%
TA
Loading chart...
Signal & projected range
Insider selling clusterHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
IndexS&P 500P/E31.95EPS (ttm)18.59Insider Own0.15%Shs Outstand371.62MPerf Week3.43%
Market Cap219.63BForward P/E21.68EPS next Y27.40Insider Trans-9.57%Shs Float370.65MPerf Month13.21%
Enterprise Value259.23BPEG2.73EPS next Q6.40Inst Own87.56%Short Float1.43%Perf Quarter25.19%
Income6.98BP/S4.76EPS this Y34.93%Inst Trans-Short Ratio2.29Perf Half Y9.52%
Sales46.34BP/B4.18EPS next Y9.25%ROA6.17%Short Interest5.30MPerf YTD2.51%
Book/sh142.10P/C54.32EPS next 5Y11.72%ROE13.35%52W High644.44 -7.76%Perf Year32.31%
Cash/sh10.94P/FCF29.16EPS past 3/5Y0.19% 2.11%ROIC7.44%52W Low435.58 36.47%Perf 3Y7.27%
Dividend Est.1.88 (0.32%)EV/EBITDA23.71Sales past 3/5Y-0.27% 6.70%Gross Margin40.37%Volatility2.59% 2.65%Perf 5Y10.00%
Dividend TTM1.80 (0.30%)EV/Sales5.59EPS Y/Y TTM12.46%Oper. Margin17.69%ATR (14)16.76Perf 10Y274.01%
Dividend Ex-DateSep 15, 2026Quick Ratio1.18Sales Y/Y TTM8.06%Profit Margin15.06%RSI (14)71.70Recom2.16
Dividend Gr. 3/5Y12.75% 14.34%Current Ratio1.55EPS Q/Q12.50%SMA206.60%Beta0.84Target Price597.67
Payout9.49%Debt/Eq0.76Sales Q/Q10.49%SMA5014.77%Rel Volume0.76Prev Close594.00
Employees125,000LT Debt/Eq0.69EarningsOct 28SMA20011.69%Avg Volume2.37MPrice594.43
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.5.43% 2.46%Net Debt/EBITDA3.52Volume1,805,688Change0.07%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-05-26ReiteratedStifel NicolausBuy$600$650
Jul-27-26ReiteratedPiper SandlerNeutral$510$600
Jul-24-26ReiteratedRBC CapitalSector Perform$490$580
Jul-23-26ReiteratedJefferiesHold$585$630
Jul-06-26ReiteratedEvercore ISI GroupOutperform$650$570
Jun-26-26ResumedBernsteinMarket Perform$520
Jun-11-26InitiatedPiper SandlerNeutral$510
Jun-03-26DowngradeHSBCBuyHold$670$540
May-14-26ResumedRBC CapitalSector Perform$561$490
Apr-27-26ReiteratedMorgan StanleyOverweight$670$620
Latest News
Aug-07-26
Aug-03-26
Aug-01-26
Jul-31-26
Jul-29-26
Jul-28-26
Jul-27-26
Jul-24-26
Jul-23-26
Company

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Ownership
Total institutional ownership87.56%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue46,33644,55642,879
Cost of Goods Sold Incl. D&A27,62927,77825,151
Gross Profit18,70716,77817,728
Selling, General and Administrative Excl. Other8,0497,2728,676
Research and Development1,4041,3971,390
Other Operating Expense
1,06200
Operating Income8,1958,1097,662
Interest Expense1,4671,4191,654
Unusual Expense
Non-Operating Income (Expense)881577987
Net Income Before Taxes7,6097,2676,995
Income Taxes597547657
Consolidated Net Income6,9786,7376,335
Net Income From Continuing Operations7,0126,7206,338
Net Income6,9786,7376,335
EPS (Recurring)18.6217.7716.58
EPS (Basic, Before Extraordinaries)18.6217.7716.58
EPS (Diluted)18.5917.7416.53
EBITDA10,93511,46611,800
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio31.9832.6631.47
Price To Sales Ratio4.764.894.63
Gross Margin40.3737.6641.34
Operating Margin17.6918.2017.87
Net Margin15.0615.1214.77
Shares Outstanding371376382
Market Capitalization220,535217,873198,728
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$676.83$595.84$514.86$433.87$352.88 Close Price0.00M14.18M28.35M42.53M56.70MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Britt Lisa P.Sr. VP and Chief HR OfficerAug 06 '26Sale580.005,8503,393,00014,784Aug 07
Britt Lisa P.Sr. VP and Chief HR OfficerAug 06 '26Option Exercise309.635,8501,811,33620,634Aug 07
CASPER MARC NChairman & CEOAug 06 '26Option Exercise309.6310,0003,096,300133,925Aug 07
CASPER MARC NChairman & CEOAug 06 '26Sale574.4615,0008,616,9674,608Aug 07
CASPER MARC NChairman & CEOAug 05 '26Option Exercise309.6310,0003,096,300133,925Aug 07
CASPER MARC NChairman & CEOAug 05 '26Sale575.2315,0008,628,4359,608Aug 07
Pettiti GianlucaPresident & COOJul 27 '26Sale565.00400226,00024,651Jul 28
Pettiti GianlucaPresident & COOApr 27 '26Sale462.66400185,06425,051Apr 29
Shafer Michael DExecutive Vice PresidentMar 11 '26Sale499.401,607802,53620,950Mar 12
CASPER MARC NChairman & CEOMar 05 '26Option Exercise309.634,0001,238,520127,925Mar 09
CASPER MARC NChairman & CEOMar 05 '26Sale514.824,0002,059,261123,925Mar 09
CASPER MARC NChairman & CEOMar 04 '26Sale512.405,0002,561,994123,925Mar 05
CASPER MARC NChairman & CEOMar 04 '26Option Exercise309.635,0001,548,150128,925Mar 05
CASPER MARC NChairman & CEOMar 03 '26Sale503.105,0002,515,494123,925Mar 05
CASPER MARC NChairman & CEOMar 03 '26Option Exercise309.635,0001,548,15049,550Mar 05
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.